1. Home
  2. AGX vs CRSP Comparison

AGX vs CRSP Comparison

Compare AGX & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$259.74

Market Cap

5.6B

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

SELL

Current Price

$48.39

Market Cap

4.8B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AGX
CRSP
Founded
1961
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.8B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
AGX
CRSP
Price
$259.74
$48.39
Analyst Decision
Buy
Buy
Analyst Count
6
23
Target Price
★ $570.50
$74.33
AVG Volume (30 Days)
282.8K
★ 1.4M
Earning Date
09-02-2026
11-02-2026
Dividend Yield
★ 0.96%
N/A
EPS Growth
★ 58.37
N/A
EPS
★ 7.01
N/A
Revenue
★ $944,606,000.00
$289,590,000.00
Revenue This Year
$48.32
$1,091.30
Revenue Next Year
$20.43
$216.80
P/E Ratio
$41.46
★ N/A
Revenue Growth
8.06
★ 9169.85
52 Week Low
$276.28
$44.12
52 Week High
$805.75
$63.45

Technical Indicators

Market Signals
Indicator
AGX
CRSP
Relative Strength Index (RSI) 29.90 49.65
Support Level N/A $50.02
Resistance Level $447.21 $60.68
Average True Range (ATR) 19.01 2.33
MACD -1.11 0.21
Stochastic Oscillator 11.62 52.19

Price Performance

Historical Comparison
AGX
CRSP

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Teledata, out of which Power Services derives the majority of revenue.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: